Avricore Financial Statements From 2010 to 2025

Stocks . Canada . 
Stock . Avricore Health
AVCR Stock  CAD 0.04  0.01  12.50%   
Avricore Health financial statements provide useful quarterly and yearly information to potential Avricore Health investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Avricore Health financial statements helps investors assess Avricore Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Avricore Health's valuation are summarized below:
Gross Profit
1.8 M
Profit Margin
0.0219
Market Capitalization
4.6 M
Enterprise Value Revenue
0.9136
Revenue
4.7 M
There are over one hundred nineteen available fundamental signals for Avricore Health, which can be analyzed over time and compared to other ratios. All traders should should validate Avricore Health's prevailing fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable. Market Cap is likely to climb to about 16 M in 2025. Enterprise Value is likely to climb to about 15.8 M in 2025

Avricore Health Total Revenue

4.21 Million

Check Avricore Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avricore Health's main balance sheet or income statement drivers, such as Selling General Administrative of 1.2 M, Other Operating Expenses of 1.7 M or Total Operating Expenses of 5 M, as well as many indicators such as Price To Sales Ratio of 4.15, Dividend Yield of 0.0 or PTB Ratio of 7.96. Avricore financial statements analysis is a perfect complement when working with Avricore Health Valuation or Volatility modules.
  
This module can also supplement various Avricore Health Technical models . Check out the analysis of Avricore Health Correlation against competitors.

Avricore Health Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.1 M2.9 M1.8 M
Slightly volatile
Total Current Liabilities409.8 K608.6 K463.1 K
Pretty Stable
Cash623.9 K318.1 K691.8 K
Very volatile
Non Current Assets Total2.1 M2 M615.3 K
Slightly volatile
Cash And Short Term Investments639.8 K725.1 K634.2 K
Pretty Stable
Net Receivables508.4 K484.1 K245.2 K
Slightly volatile
Common Stock Shares Outstanding120.3 M114.6 M46.2 M
Slightly volatile
Liabilities And Stockholders Equity3.1 M3 M1.8 M
Slightly volatile
Total Liabilities422 K608.6 K465.7 K
Pretty Stable
Total Current Assets1.1 M889.6 K1.2 M
Very volatile
Common Stock20.6 M31.1 M19.4 M
Slightly volatile
Accounts Payable517.6 K493 K248.9 K
Slightly volatile
Other Stockholder Equity7.2 M6.7 M8.3 M
Pretty Stable
Accumulated Other Comprehensive Income7.2 M6.8 M4.6 M
Slightly volatile
Other Current Liabilities43.9 K46.3 K143.2 K
Slightly volatile
Other Current Assets33 K34.8 K134.9 K
Slightly volatile
Intangible Assets39.9 K42 K434.3 K
Slightly volatile
Short Term Investments8.6 K9 K127 K
Slightly volatile
Property Plant Equipment59.8 K104.5 K62.3 K
Slightly volatile
Capital Stock26.6 M31.3 M23.1 M
Slightly volatile
Short and Long Term Debt Total34.2 K36 K87.9 K
Pretty Stable
Short Term Debt34.2 K36 K87.9 K
Pretty Stable
Short and Long Term Debt34.2 K36 K700.5 K
Slightly volatile

Avricore Health Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative1.2 M2.1 M1.2 M
Slightly volatile
Other Operating Expenses1.7 M3 M1.9 M
Slightly volatile
Total Operating Expenses5 M4.8 M2.1 M
Slightly volatile
Income Tax Expense50.5 K44.2 K66.9 K
Very volatile
Depreciation And Amortization221 K210.5 K106.9 K
Slightly volatile
Total Revenue4.2 M4 M981.1 K
Slightly volatile
Gross Profit1.5 M1.4 M333.4 K
Slightly volatile
Selling And Marketing Expenses335.9 K202.4 K203.3 K
Pretty Stable
Research Development303.7 K289.2 K173.7 K
Slightly volatile
Cost Of Revenue2.8 M2.6 M655.5 K
Slightly volatile
Reconciled Depreciation507.2 K483.1 K156.7 K
Slightly volatile

Avricore Health Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Cash From Financing Activities46.4 K48.9 K1.1 M
Pretty Stable
End Period Cash Flow623.9 K318.1 K691.8 K
Very volatile
Begin Period Cash Flow537.1 K713.6 K694.3 K
Pretty Stable
Depreciation507.2 K483.1 K150.6 K
Slightly volatile
Stock Based Compensation445.5 K809.2 K478.6 K
Very volatile
Change To Netincome857.9 K480.8 K1.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.154.37718
Slightly volatile
Days Sales Outstanding48.9451.51648
Slightly volatile
Average Payables301.8 K287.4 K225.8 K
Slightly volatile
Stock Based Compensation To Revenue0.220.2341.5433
Slightly volatile
Capex To Depreciation3.522.249.007
Slightly volatile
Inventory Turnover10499.3247.5137
Slightly volatile
Days Of Inventory On Hand2.832.9813.5 K
Slightly volatile
Payables Turnover3.096.122.3385
Slightly volatile
Sales General And Administrative To Revenue0.450.4860.921
Slightly volatile
Research And Ddevelopement To Revenue1.091.02.492
Slightly volatile
Capex To Revenue0.470.271.7452
Slightly volatile
Cash Per Share0.00310.00330.1531
Slightly volatile
Days Payables Outstanding58.6361.727.4 K
Slightly volatile
Intangibles To Total Assets0.02010.02110.2154
Slightly volatile
Current Ratio1.61.686.0114
Pretty Stable
Receivables Turnover9.849.373.2847
Slightly volatile
Capex Per Share0.02210.01210.0081
Very volatile
Average Receivables407.3 K387.9 K233.8 K
Slightly volatile
Revenue Per Share0.03820.04030.0229
Very volatile
Interest Debt Per Share5.0E-45.0E-40.0044
Slightly volatile
Debt To Assets0.01720.01810.2233
Very volatile
Graham Number0.280.320.3478
Slightly volatile
Operating Cycle41.1243.2910.9 K
Slightly volatile
Days Of Payables Outstanding58.6361.727.4 K
Slightly volatile
Long Term Debt To Capitalization0.05060.05680.062
Slightly volatile
Quick Ratio1.551.645.362
Pretty Stable
Net Income Per E B T0.820.991.0679
Slightly volatile
Cash Ratio0.570.64.3471
Pretty Stable
Days Of Inventory Outstanding2.832.9813.5 K
Slightly volatile
Days Of Sales Outstanding48.9451.51648
Slightly volatile
Fixed Asset Turnover2.222.334.2412
Very volatile
Debt Ratio0.01720.01810.2233
Very volatile
Price Sales Ratio4.154.37718
Slightly volatile
Asset Turnover1.31.240.6248
Very volatile

Avricore Health Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap16 M15.2 M10.4 M
Slightly volatile

About Avricore Health Financial Statements

Avricore Health investors use historical fundamental indicators, such as Avricore Health's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Avricore Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue289.8 K304.3 K
Total Revenue4 M4.2 M
Cost Of Revenue2.6 M2.8 M
Stock Based Compensation To Revenue 0.23  0.22 
Sales General And Administrative To Revenue 0.48  0.45 
Research And Ddevelopement To Revenue 1.00  1.09 
Capex To Revenue 0.27  0.47 
Revenue Per Share 0.04  0.04 
Ebit Per Revenue(0.23)(0.24)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Avricore Stock Analysis

When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY